GTBP drug pipeline is very solid, and the website is Content rich. Plus this is a fully reporting company, by the looks the chart is starting to stabilize.
if OXS-1550 or OXS-3550 are approved, the company estimated is worth over 1 billion dollars. Early data (in vivo) for TriKE for liquid tumors looks very promising, and if all goes as planned, could go through the clinic much faster than OXS-1550. I think the real value in this company is in OXS-3550 which clearly on the picture as stated above
News 
Market Data 
Discover 
